A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

NCT00740623 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial, Motor
Epilepsy, Complex Partial
Epilepsy, Simple Partial
Focal Motor Epilepsy

Interventions

DRUG: Carisbamate
DRUG: placebo
DRUG: Carisbamate

Sponsor

SK Life Science, Inc.